Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma
University of California, San Diego
University of California, San Diego
HiberCell, Inc.
Groupe Oncologie Radiotherapie Tete et Cou
UNC Lineberger Comprehensive Cancer Center
Daiichi Sankyo
Seagen Inc.
University of Chicago
Merck KGaA, Darmstadt, Germany
Eli Lilly and Company